HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

ACOR: Acorda Therapeutics Inc - Detailed Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage
ACORDA THERAPEUTICS INC (NASD)
ACOR 24.30 0.04 (0.16%) Vol.  295,994 15:59 ET
Last 24.30 Bid / Size 23.63x1000
Net  0.04 Ask / Size 24.31x100
% Change  0.16 52 Wk High 29.27
High 24.56 52 Wk Low 14.89
Low 24.00 Volume 295,994
 
Insider Ownership N/A% S&P 500 Member NO
Institutional Ownership 94.3% Beta .63
P/E (TTM) PEG Ratio
PE (forward) Price / Sales 17.52
 
Dividend N/A
Dividend Yield 0
Last Dividend Date N/A
5 Year Avg. Yield 0
Dividend Payout Ratio
 
Shares Outstanding 38,064,000
Market Capitalization 924,955,200
Last Split Date N/A
Split Factor N/A
Short Interest Ratio 1.33
 
% Change
4 Weeks 4.12
12 Weeks 6.97
52 Weeks 50.96
 
% Change Relative to S&P 500
4 Weeks 1.61
12 Weeks -.51
52 Weeks 9.18

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research